scispace - formally typeset
Open AccessJournal ArticleDOI

CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury.

Reads0
Chats0
TLDR
CHIP-mediated protein turnover is markedly post-translationally enhanced by direct protein kinase G phosphorylation at S20 (mouse, S19 human), which increases CHIP binding affinity to Hsc70, CHIP protein half-life, and consequent clearance of stress-induced ubiquitinated-insoluble proteins.
Abstract
Proteotoxicity from insufficient clearance of misfolded/damaged proteins underlies many diseases. Carboxyl terminus of Hsc70-interacting protein (CHIP) is an important regulator of proteostasis in many cells, having E3-ligase and chaperone functions and often directing damaged proteins towards proteasome recycling. While enhancing CHIP functionality has broad therapeutic potential, prior efforts have all relied on genetic upregulation. Here we report that CHIP-mediated protein turnover is markedly post-translationally enhanced by direct protein kinase G (PKG) phosphorylation at S20 (mouse, S19 human). This increases CHIP binding affinity to Hsc70, CHIP protein half-life, and consequent clearance of stress-induced ubiquitinated-insoluble proteins. PKG-mediated CHIP-pS20 or expressing CHIP-S20E (phosphomimetic) reduces ischemic proteo- and cytotoxicity, whereas a phospho-silenced CHIP-S20A amplifies both. In vivo, depressing PKG activity lowers CHIP-S20 phosphorylation and protein, exacerbating proteotoxicity and heart dysfunction after ischemic injury. CHIP-S20E knock-in mice better clear ubiquitinated proteins and are cardio-protected. PKG activation provides post-translational enhancement of protein quality control via CHIP.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.

TL;DR: In this article, the authors highlight several targeted therapies commonly used across a variety of cancer types, including HER2 (human epidermal growth factor receptor 2)+ targeted therapies, tyrosine kinase inhibitors, immune checkpoint inhibitors, proteasome inhibitors, androgen deprivation therapies, and MEK (mitogenactivated protein kinase kinase)/BRAF (v-raf murine sarcoma viral oncogene homolog B) inhibitors.
Journal Article

Promotion of Chip-Mediated P53 Degradation Protects the Heart From Ischemic Injury

Atsuhiko T. Naito
- 28 Oct 2008 - 
TL;DR: It is found that downregulation of CHIP level by hypoxia was responsible for p53 accumulation in the heart after myocardial infarction and decreasing the amount of p53 prevented myocardian apoptosis and ameliorated ventricular remodeling after my Cardiomyocyte remodeling.
Journal Article

Abstract 300: Protein Kinase G Positively Regulates Proteasome-mediated Degradation of Misfolded Proteins

TL;DR: STimulation of PKG by measures such as sildenafil administration is potentially a new therapeutic strategy to treat cardiac proteinopathies.
Journal ArticleDOI

cGMP and mitochondrial K + channels-Compartmentalized but closely connected in cardioprotection

TL;DR: In this article, the 3'5'-cGMP pathway triggers cytoprotective responses and improves cardiomyocyte survival during myocardial ischaemia and reperfusion (I/R) injury.
References
More filters
Journal ArticleDOI

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

TL;DR: A general mass spectrometric technology is developed and applied for identification and quantitation of phosphorylation sites as a function of stimulus, time, and subcellular location to provide a missing link in a global, integrative view of cellular regulation.
Journal ArticleDOI

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

TL;DR: A large-scale phosphorylation data set is provided with a measured error rate as determined by the target-decoy approach, an approach to maximize data set sensitivity by efficiently distracting incorrect peptide spectral matches (PSMs) is demonstrated, and a probability-based score is presented, the Ascore, that measures the probability of correct phosphorylated site localization based on the presence and intensity of site-determining ions in MS/MS spectra.
Journal ArticleDOI

Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions

TL;DR: Results indicate that CHIP decreases net ATPase activity and reduces chaperone efficiency, and they implicate CHIP in the negative regulation of the forward reaction of the Hsc70-Hsp70 substrate-binding cycle.
Journal ArticleDOI

The coming of age of chaperone-mediated autophagy.

TL;DR: These findings expand the physiological relevance of CMA beyond its originally identified role in protein quality control and reveal that CMA failure with age may aggravate diseases, such as ageing-associated neurodegeneration and cancer.
Related Papers (5)